Article Details

Xeris Biopharma Announces U.S. FDA Approval of Recorlev® (levoketoconazole) for the ...

Retrieved on: 2021-12-30 21:48:50

Tags for this article:

Click the tags to see associated articles and topics

Xeris Biopharma Announces U.S. FDA Approval of Recorlev® (levoketoconazole) for the .... View article details on hiswai:

Excerpt

CHICAGO, December 30, 2021--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up